Hans Loibner - Concepedia

Author

Hans Loibner

Apeiron Biologics (Austria)ORCID

Also Known As

H LOIBNER, H Loibner, H. LOIBNER, H. Loibner, HANS LOIBNER, Hans Loibner, Stephen D. Gillies

177

Publications

5.6K

Citations

H-Index

107

Concepts

All Affiliations

Apeiron Biologics (Austria)St Anna Children's Hospital Universitätsmedizin Greifswald Austrian Academy of Sciences Institute of Molecular Biotechnology

About

Hans Loibner is an author at Apeiron Biologics (Austria) specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	26	2K
2	Engineering	5	5	459
3	Natural Sciences	4	4	652
4	Health Sciences	3	3	97
5	Public Health	1	1	100

Hans Loibner

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer Michael Stotz, Armin Gerger, Florian Eisner, British Journal of Cancer	2013	490
Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction Jiuchang Zhong, Ratnadeep Basu, Danny Guo, Circulation	2010	453
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial Ruth Ladenstein, Ulrike Pötschger, Dominique Valteau‐Couanet, The Lancet Oncology Interleukin 2Autoimmune DiseaseAnti-gd2 Antibody Ch14.18/choImmunologyPathology	2018	379
Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects Manuel Haschke, Manfred Schuster, Marko Poglitsch, Clinical Pharmacokinetics HypertensionCardiovascular DiseaseMedicineAntihypertensive TherapyCardiovascular Pharmacology	2013	373
Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2 Jan Wysocki, Minghao Ye, Eva Rodríguez, Hypertension HypertensionAng Ii InfusionCardiovascular PharmacologyAng IiBlood Pressure	2009	302
Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy Gavin Y. Oudit, George C. Liu, Jiuchang Zhong, Diabetes	2009	301
Reaktionen mit phosphororganischen Verbindungen. XLI[1]. Neuartige synthetische Aspekte des Systems Triphenylphosphin‐Azodicarbonsäureester‐Hydroxyverbindung Hans Loibner, Erich Zbiral Helvetica Chimica Acta Systems Triphenylphosphin‐azodicarbonsäureester‐hydroxyverbindungBiosynthesisBioorganic ChemistryEngineeringBiochemistry	1976	229
Prevention of Angiotensin II–Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2 Jiuchang Zhong, Danny Guo, Christopher B. Chen, Hypertension	2010	226
Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1) Ruth Ladenstein, Ulrike Pötschger, Dominique Valteau‐Couanet, Cancers	2020	139
Comparison of two methods for enumerating circulating tumor cells in carcinoma patients Marija Balić, Nadia Dandachi, Günter Hofmann, Cytometry Part B Clinical Cytometry	2005	134

Page 1